BioLineRx Ltd. Selling, General and Administrative Expense
BioLineRx Ltd. (BLRX) reported Selling, General and Administrative Expense of $3.14 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SellingGeneralAndAdministrativeExpense · last filed 2026-03-23
- BioLineRx Ltd. selling general and administrative expense for the quarter ending 2025-06-30 was $209.00K, a 87.17% decline year-over-year.
- BioLineRx Ltd. selling general and administrative expense for the quarter ending 2024-06-30 was $1.63M, a 24.83% increase year-over-year.
- BioLineRx Ltd. selling general and administrative expense for the quarter ending 2023-06-30 was $1.30M, a 24.40% increase year-over-year.
- BioLineRx Ltd. selling general and administrative expense for the quarter ending 2022-06-30 was $1.05M, a 0.48% increase year-over-year.
| Period end | Selling General And Administrative Expense 3 month | Selling General And Administrative Expense 6 month | Selling General And Administrative Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $3.14M 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $209.00K 6-K · filed 2025-08-14 | $1.20M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $6.32M 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $1.63M 6-K · filed 2025-08-14 | $3.02M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $6.31M 20-F · filed 2026-03-23 | ||
| 2023-06-30 | $1.30M 6-K · filed 2024-08-15 | $2.60M 6-K · filed 2024-08-15 | |
| 2022-12-31 | $5.07M 20-F · filed 2025-03-31 | ||
| 2022-06-30 | $1.05M 6-K · filed 2023-08-30 | $2.06M 6-K · filed 2023-08-30 | |
| 2021-12-31 | $4.31M 20-F · filed 2024-03-26 | ||
| 2021-06-30 | $1.04M 6-K · filed 2022-08-16 | $2.06M 6-K · filed 2022-08-16 | |
| 2020-12-31 | $3.91M 20-F · filed 2023-03-22 | ||
| 2020-06-30 | $744.00K 6-K · filed 2021-08-18 | $1.99M 6-K · filed 2021-08-18 | |
| 2019-12-31 | $3.82M 20-F · filed 2022-03-16 | ||
| 2019-06-30 | $949.00K 6-K · filed 2020-08-06 | $1.88M 6-K · filed 2020-08-06 | |
| 2018-12-31 | $4.43M 20-F · filed 2021-02-23 | ||
| 2018-06-30 | $883.00K 6-K · filed 2019-08-06 | $1.96M 6-K · filed 2019-08-06 | |
| 2017-12-31 | $4.04M 20-F · filed 2020-03-12 | ||
| 2017-06-30 | $844.00K 6-K · filed 2018-08-13 | $1.87M 6-K · filed 2018-08-13 | |
| 2016-12-31 | $3.98M 20-F · filed 2019-03-28 | ||
| 2015-12-31 | $3.70M 20-F · filed 2018-03-06 |